regeneron 23andme - Search News

Order byBest matchMost fresh

23andMe, Regeneron

Regeneron buying 23andMe; What happened to 23andMe? Should I delete 23andMe data?

California Attorney General Rob Bonta urged customers to consider directing 23andMe to delete their data and destroy their DNA.

· 4h

· 1d · on MSN

Regeneron Pharmaceuticals to buy 23andMe for $256M

· 1d · on MSN

Regeneron to buy bankrupt DNA testing firm 23andMe for $256 million

Struggling DNA testing firm 23andMe to be bought for $256m

23andMe says it has entered into an agreement to be acquired by Regeneron Pharmaceuticals for $256m (£192m).

· 1d

23andMe (and Your Genetic Data) Sold to Regeneron in Bankruptcy Auction

Regeneron to Buy 23andMe Out of Bankruptcy for $256 Million

23andMe sells its most valuable asset to biotech company Regeneron, which promises to keep your DNA private

Regeneron said Monday it will “prioritize the privacy, security and ethical use” of the personal DNA data from about 15 million people in a $256 million deal to acquire assets of bankrupt 23andMe Hold...

· 1d

Biotechnology company Regeneron buying 23andMe for $256 million

· 1d

Bankrupt DNA testing company 23andMe to be bought by Regeneron

MassDevice9h

Regeneron to acquire 23andMe for $256M, plans to continue consumer genetics services

Regeneron Pharmaceuticals is set to acquire substantially all assets of 23andMe for $256 million. The deal is expected to close in Q3 2025

Daily Voice on MSN12h

Westchester-Based Regeneron Buying Bankrupt 23andMe For $256M, Pledges To Protect DNA Data

Regeneron Pharmaceuticals will acquire embattled DNA testing company 23andMe in a $256 million court-supervised sale, promising to honor existing privacy protections and continue consumer services with no changes.

1don MSN

Regeneron agrees to buy bankrupt 23andMe, promises ethical use of customers' DNA data

Regeneron Pharmaceuticals said on Monday it will buy genetic testing firm 23andMe Holding for $256 million through a bankruptcy auction, and promised to prioritize the ethical use of customers' DNA data.

STAT7h

Regeneron makes another deal — This one about AI

Regeneron has been busy, with two health tech deals announced this week: One is about genetic data and one about AI. Both of them are about developing and selling drugs, really.

The Verge1d

23andMe and its user data will soon belong to a pharmaceutical giant

23andMe will keep offering customers its DNA testing services after being bought out of bankruptcy. New York-based biotech company Regeneron Pharmaceuticals announced an agreement on Monday to purchase the 23andMe startup for $256 million, alongside its ...

Explore more

DNA

Biotechnology